Goldman Sachs’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10
| Closed | -$15K | – | 5721 |
|
|
2021
Q3 | $15K | Sell |
10
-59
| -86% | -$88.5K | ﹤0.01% | 5308 |
|
|
2021
Q2 | $120K | Buy |
69
+28
| +68% | +$48.7K | ﹤0.01% | 5077 |
|
|
2021
Q1 | $87K | Buy |
+41
| New | +$87K | ﹤0.01% | 5061 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$10K | – | 4350 |
|
|
2018
Q1 | $10K | Hold |
2
| – | – | ﹤0.01% | 4173 |
|
|
2017
Q4 | $10K | Sell |
2
-2
| -50% | -$10K | ﹤0.01% | 4126 |
|
|
2017
Q3 | $28K | Hold |
4
| – | – | ﹤0.01% | 4169 |
|
|
2017
Q2 | $55K | Buy |
4
+2
| +100% | +$27.5K | ﹤0.01% | 4239 |
|
|
2017
Q1 | $36K | Hold |
2
| – | – | ﹤0.01% | 4256 |
|
|
2016
Q4 | $37K | Sell |
2
-1
| -33% | -$18.5K | ﹤0.01% | 4270 |
|
|
2016
Q3 | $61K | Hold |
3
| – | – | ﹤0.01% | 4273 |
|
|
2016
Q2 | $43K | Hold |
3
| – | – | ﹤0.01% | 4291 |
|
|
2016
Q1 | $49K | Hold |
3
| – | – | ﹤0.01% | 4224 |
|
|
2015
Q4 | $29K | Sell |
3
-1
| -25% | -$9.67K | ﹤0.01% | 4308 |
|
|
2015
Q3 | $43K | Buy |
4
+1
| +33% | +$10.8K | ﹤0.01% | 4367 |
|
|
2015
Q2 | $59K | Hold |
3
| – | – | ﹤0.01% | 4408 |
|
|
2015
Q1 | $63K | Sell |
3
-1
| -25% | -$21K | ﹤0.01% | 4250 |
|
|
2014
Q4 | $119K | Buy |
4
+1
| +33% | +$29.8K | ﹤0.01% | 4203 |
|
|
2014
Q3 | $94K | Hold |
3
| – | – | ﹤0.01% | 4245 |
|
|
2014
Q2 | $77K | Buy |
3
+2
| +200% | +$51.3K | ﹤0.01% | 4236 |
|
|
2014
Q1 | $25K | Buy |
+1
| New | +$25K | ﹤0.01% | 4278 |
|